These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 38285765)

  • 1. Current State of Knowledge on Blood and Tissue-Based Biomarkers for Opisthorchis viverrini-induced Cholangiocarcinoma: A Review of Prognostic, Predictive, and Diagnostic Markers.
    Kafle A; Suttiprapa S
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):25-41. PubMed ID: 38285765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid assessment of Opisthorchis viverrini IgG antibody in serum: A potential diagnostic biomarker to predict risk of cholangiocarcinoma in regions endemic for opisthorchiasis.
    Rodpai R; Luvira V; Sadaow L; Sukeepaisarnjaroen W; Kitkhuandee A; Paonariang K; Sanpool O; Ittiprasert W; Mann VH; Intapan PM; Brindley PJ; Maleewong W
    Int J Infect Dis; 2022 Mar; 116():80-84. PubMed ID: 34954313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Potential Biomarkers for
    Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
    In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes mellitus: Possible risk and promoting factors of cholangiocarcinoma: Association of diabetes mellitus and cholangiocarcinoma.
    Saengboonmee C; Seubwai W; Wongkham C; Wongkham S
    Cancer Epidemiol; 2015 Jun; 39(3):274-8. PubMed ID: 25910864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Biomarkers and the Wnt/β-Catenin Pathway in Opisthorchis viverrini-associated Cholangiocarcinoma: A Scoping Review on Therapeutic Opportunities.
    Kafle A; Suttiprapa S; Muhammad M; Tenorio JCB; Mahato RK; Sahimin N; Loong SK
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012477. PubMed ID: 39236081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta as a potential biomarker for
    Prasopdee S; Yingchutrakul Y; Roytrakul S; Pholhelm M; Phanaksri T; Kunjantarachot A; Kulsantiwong J; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
    Parasitology; 2022 Feb; 149(2):171-180. PubMed ID: 35234600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wound healing and cancer progression in Opisthorchis viverrini associated cholangiocarcinoma.
    Botelho MC; Alves H; Richter J
    Parasitol Res; 2016 Jul; 115(7):2913-4. PubMed ID: 27130317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA profiling of exosomes derived from plasma and their potential as biomarkers for Opisthorchis viverrini-associated cholangiocarcinoma.
    Supradit K; Wongprasert K; Tangphatsornruang S; Yoocha T; Sonthirod C; Pootakham W; Thitapakorn V; Butthongkomvong K; Phanaksri T; Kunjantarachot A; Klongprateeppon H; Sattavacharavech P; Prasopdee S
    Acta Trop; 2024 Oct; 258():107362. PubMed ID: 39151716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Control of Opisthorchis viverrini infection for cholangiocarcinoma prevention].
    Buisson Y
    Bull Soc Pathol Exot; 2017 Feb; 110(1):61-67. PubMed ID: 28105582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of Plasma Cell-Free DNA and MiRNA in Cholangiocarcinoma and Opisthorchiasis Viverrini Patients.
    Prasopdee S; Pholhelm M; Yusuk S; Tangphatsornruang S; Butthongkomvong K; Kunjantarachot A; Phanaksri T; Kulsantiwong J; Tesana S; Thitapakorn V
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):739-746. PubMed ID: 38546056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of salivary antibodies to crude antigens of Opisthorchis viverrini in opisthorchiasis and cholangiocarcinoma patients.
    Chaiyarit P; Sithithaworn P; Thuwajit C; Yongvanit P
    Clin Oral Investig; 2011 Aug; 15(4):477-83. PubMed ID: 20446100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasonography as a tool for monitoring the development and progression of cholangiocarcinoma in Opisthorchis viverrini/ dimethylnitrosamine-induced hamsters.
    Plengsuriyakarn T; Eursitthichai V; Labbunruang N; Na-Bangchang K; Tesana S; Aumarm W; Pongpradit A; Viyanant V
    Asian Pac J Cancer Prev; 2012; 13(1):87-90. PubMed ID: 22502719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
    Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
    Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the risk factors for opisthorchiasis and cholangiocarcinoma in Thailand.
    Prasopdee S; Rojthongpond T; Chitkoolsamphan Y; Pholhelm M; Yusuk S; Pattaraarchachai J; Butthongkomvong K; Kulsantiwong J; Phanaksri T; Kunjantarachot A; Tesana S; Sathavornmanee T; Thitapakorn V
    Parasites Hosts Dis; 2023 Nov; 61(4):463-470. PubMed ID: 38043542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opisthorchis Felineus Infection is a Risk Factor for Cholangiocarcinoma in Western Siberia: A Hospital-based Case-control Study.
    Fedorova OS; Kovshirina AE; Kovshirina YV; Hattendorf J; Onishchenko SV; Katanakhova LL; Taslicki SS; Chizhikov AV; Tataurov IA; Vtorushin SV; Sripa B; Ogorodova LM; Odermatt P
    Clin Infect Dis; 2023 Feb; 76(3):e1392-e1398. PubMed ID: 35723279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P; Pinlaor S; Loilome W
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of comorbidity between Opisthorchis viverrini infection and diabetes mellitus in the development of cholangiocarcinoma among a high-risk population, northeastern Thailand.
    Thinkhamrop K; Khuntikeo N; Laohasiriwong W; Chupanit P; Kelly M; Suwannatrai AT
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009741. PubMed ID: 34543283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma checkpoint protein 1 (Chk1) as a potential diagnostic biomarker for opisthorchiasis and cholangiocarcinoma.
    Phanaksri T; Yingchutrakul Y; Roytrakul S; Prasopdee S; Kunjantarachot A; Butthongkomvong K; Tesana S; Sathavornmanee T; Thitapakorn V
    Cancer Biomark; 2022; 33(1):43-55. PubMed ID: 34366327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.